Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: The Boots Company PLC, 1 Thane Road West, Nottingham, NG2 3AA Trading as: BCM
Almus Decongestant Nasal Spray.
Boots Blocked Nose Relief 0.05% w/v Nasal Spray.
| Pharmaceutical Form |
|---|
|
Nasal Spray. |
Active ingredient %w/v: Oxymetazoline hydrochloride 0.05%.
| Active Ingredient | Description | |
|---|---|---|
| Oxymetazoline |
Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa. |
| List of Excipients |
|---|
|
Monosodium phosphate fine cryst |
A 22ml polypropylene bottle with a polythene plug and elongated nozzle dip tube fitted with a wadless polythene cap that fits the elongated nozzle.
The Boots Company PLC, 1 Thane Road West, Nottingham, NG2 3AA
Trading as: BCM
PL00014/0292
24 July 1989
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
